PRESS RELEASE published on 10/25/2024 at 07:00, 1 year 8 months ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first nine months of 2024, showing a net profit and strategic investment details Investment Company Net Profit BB Biotech AG Interim Report Stocks
PRESS RELEASE published on 10/25/2024 at 07:00, 1 year 8 months ago BB Biotech: Strategic reallocation of portfolio assets progressing BB Biotech AG reports strategic portfolio reallocation progress in Q3 2024 amid market volatility, focusing on promising biotech investments. Key companies achieve milestones Investment BB Biotech AG Biotech Sector Milestones Portfolio Reallocation
BRIEF published on 10/23/2024 at 10:17, 1 year 8 months ago BB Biotech Sees Positive Developments Amid Sector Challenges Investment Opportunity Biotech Sector BB Biotech Share Price Discount RNA Editing
BRIEF published on 10/23/2024 at 10:17, 1 year 8 months ago BB Biotech constate une évolution positive malgré les défis du secteur Opportunité D'investissement Secteur Biotechnologique Biotechnologie BB Édition D'ARN Rabais Sur Le Prix De L'action
PRESS RELEASE published on 10/23/2024 at 10:12, 1 year 8 months ago Edison issues report on BB Biotech (BION) Edison releases report on BB Biotech, highlighting positive developments in genetic medicine and revenue prospects, offering investment opportunity at a wide discount Investment Opportunity Edison Discount BB Biotech Genetic Medicine
BRIEF published on 07/26/2024 at 07:05, 1 year 11 months ago BB Biotech AG Publishes Interim Report and Announces Leadership Change Investment Management Net Profit Interim Report Leadership Change BB Biotech
BRIEF published on 07/26/2024 at 07:05, 1 year 11 months ago BB Biotech AG publie un rapport intermédiaire et annonce un changement de direction Changement De Direction Bénéfice Net Gestion Des Investissements BB Biotechnologie Rapport Intérimaire
BRIEF published on 07/26/2024 at 07:05, 1 year 11 months ago Significant Pipeline Progress at BB Biotech Offsets Market Volatility Portfolio Performance Market Volatility Biotech Sector Leadership Change BB Biotech
BRIEF published on 07/26/2024 at 07:05, 1 year 11 months ago Des progrès significatifs dans le pipeline chez BB Biotech compensent la volatilité du marché Changement De Direction Volatilité Du Marché Performance Du Portefeuille BB Biotechnologie Secteur Biotechnologique
PRESS RELEASE published on 07/26/2024 at 07:00, 1 year 11 months ago EQS-Adhoc: BB Biotech AG publishes its interim report and announces a new head of its investment management team BB Biotech AG releases interim report for H1 2024, reports CHF 173mn net profit. Dr. Christian Koch appointed as new head of investment management team Net Profit BB Biotech AG Interim Report Leadership Change Investment Management Team
Published on 06/27/2026 at 16:50, 15 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 15 hours 25 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 17 hours 5 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 18 hours 5 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 18 hours 15 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 17 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 17 hours 1 minute ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 17 hours 29 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 17 hours 29 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 17 hours 38 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 23 hours 20 minutes ago Descriptif du programme de rachat d'actions
